当前位置: »论坛 › 科研专区 › 文献互助› Phase II Study of BCMA Chimeric Antigen Receptor T-C ...

[ASCO] Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)

wudaoxiang 发表于昨天 17:49 | 显示全部楼层 |阅读模式

此帖将于 2026-10-11 17:48 自动关闭

悬赏10积分

期刊：Journal of Clinical Oncology

文献作者：Wenqiang Yan; Chenxing Du; Rui Lv; Hesong Zou; Shuaishuai Zhang; Tengteng Yu; Yuting Yan; Yanlei Zhang; Shuixiu Peng; Tingyu Wang; Shuhui Deng; Wenyang Huang; Shuhua Yi; Dehui Zou; Tao Cheng; Jianxiang Wang; Alex H. Chang; Lugui Qiu; Gang An

出版日期：2026-4-10

DOI号：10.1200/jco-25-01969

下载链接：https://ascopubs.org/doi/pdfdirect/10.1200/JCO-25-01969

文献链接：https://doi.org/10.1200/jco-25-01969

当前文献来源于 American Society of Clinical Oncology (ASCO)。

备注信息：

使用道具捐赠获取积分应助有误反馈

全部回复0 显示全部楼层

发表回复

wudaoxiang Lv.2

注册会员

发布
回复
积分
210

[ASCO] Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ASCO] Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001) 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ASCO] Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)